CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.

This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.

CTT Pharma
813-606-0060

SOURCE: CTT Pharmaceutical Holdings, Inc.



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.27
+0.16 (0.07%)
AAPL  293.08
-1.22 (-0.41%)
AMD  519.74
-0.11 (-0.02%)
BAC  57.73
-0.18 (-0.31%)
GOOG  345.04
-1.04 (-0.30%)
META  557.67
-4.53 (-0.81%)
MSFT  365.46
-8.48 (-2.27%)
NVDA  199.00
-1.04 (-0.52%)
ORCL  157.53
-7.63 (-4.62%)
TSLA  375.53
-6.08 (-1.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.